NBIX

Q: What is the price of Neurocrine (NBIX) today?

The price of Neurocrine (NBIX) today is $ 144.17, with return of 14.86% compared to the last year. The price of Neurocrine (NBIX) started the year trading around $ 136.50 and today it is at $ 144.17. Follow the real-time price chart, the historical price of Neurocrine (NBIX) and international markets.

Q: When does Neurocrine (NBIX) pay dividends?

Neurocrine (NBIX) did not distribute dividends in the last year.

Q: Is Neurocrine (NBIX) worth it?

Currently, Neurocrine (NBIX) is priced at $ 144.17, with a P/E of 33.13%, representando um desvio de 5,779% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 14.86 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 14.86%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Neurocrine (NBIX) stock?

Investing in stocks of Neurocrine (NBIX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Neurocrine (NBIX) yield today?

The yield of Neurocrine (NBIX) was 5.05% in the last month, 14.86% in the last year and 55.08% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Neurocrine (NBIX) today, the total investment would be $ 14,416.50, based on the current price of $ 144.17.If past performance were to repeat, the return on your investment would be:In 1 year: $ 16,558.79In 5 years: $ 22,357.11In 10 years: $ 38,295.99It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Neurocrine Biosciences Inc.

Price

$ 144.17

return (12m)

14.86%

p/e

33.13

p/bv

4.72

DIVIDEND YIELD

0.00%

price NBIX

BVMF

NBIX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of NBIX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

5.05%

3 months

8.48%

1 year

14.86%

2 years

28.28%

5 years

55.08%

10 years

165.64%

Fundamentals NBIX

review the fundamentals of Neurocrine shares

P/E

33.13

Sector: -3.36 Industry: -3.36

P/SALES RATIO (PSR)

5.28

Sector: -3.68 Industry: -3.68

P/BV

4.72

Sector: 1.85 Industry: 1.85

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

10.03%

Sector: -63.82% Industry: -63.82%

ROE

14.25%

Sector: -68.46% Industry: -68.46%

ROIC

24.57%

Sector: -2,097.61% Industry: -2,097.61%

NET MARGIN

15.95%

Sector: -42.90% Industry: -42.90%

GROSS MARGIN

98.37%

Sector: 40.02% Industry: 40.02%

OPERATING MARGIN

20.64%

Sector: -41.98% Industry: -41.98%

P/EBITDA

23.13

Sector: -3.46 Industry: -3.46

P/EBIT

24.31

Sector: -3.62 Industry: -3.62

P/ASSET

3.32

Sector: 1.36 Industry: 1.36

BVPS

30.34

Sector: 1.80 Industry: 1.80

EPS

4.32

Sector: -2.12 Industry: -2.12

EQUITY RATIO

0.70

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

20.73%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

1.00%

Sector: - Industry: -

FAIR VALUE OF Neurocrine ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 144.17

Fair Value

$ 0.00

Upside Return potential.

-62.33%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NBIX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	17.89	0.00	0.00%	2.72%	$ 449.26 B	27.26%
PFE	13.89	1.47	10.56%	7.12%	$ 136.48 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.17	7.60	57.70%	3.69%	$ 203.00 B	32.78%
MRK	11.32	0.00	0.00%	3.76%	$ 215.53 B	29.63%
AZN	27.91	5.71	20.45%	1.85%	$ 262.37 B	16.17%
BMY	15.74	5.11	32.47%	5.31%	$ 95.06 B	12.57%
GILD	18.21	6.88	37.80%	2.64%	$ 147.72 B	27.88%
ZTS	20.09	9.87	49.11%	1.61%	$ 53.27 B	28.21%
HALO	13.41	15.84	118.17%	0.00%	$ 7.98 B	47.91%
REGN	14.94	2.21	14.79%	0.40%	$ 68.38 B	32.13%
AMGN	24.59	17.91	72.82%	2.93%	$ 172.27 B	19.47%
VRTX	28.52	6.05	21.22%	0.00%	$ 104.82 B	31.35%
MCK	26.20	-182.78	-697.75%	0.35%	$ 105.65 B	1.04%
CAH	30.39	-17.75	-58.40%	1.00%	$ 48.47 B	0.68%
ADMA	16.57	8.05	48.57%	0.00%	$ 3.47 B	42.87%
BIIB	14.21	1.26	8.83%	0.00%	$ 22.86 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NBIX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Neurocrine

Neurocrine Biosciences Inc.

Average user rating I10

4.0 (3 people)

United States

33 years

Founded: 1992

1996

Time since IPO - 29 years

845

Employees

The Company Neurocrine Biosciences Inc. (United States), is listed on Nasdaq with a market cap of $ 14.18 Billions, having an equity of $ 3.00 Billions.

With a total of 845 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 2.68 Billions, which generated a profit in the amount of $ 428.00 Millions.

As for its main indicators, the Company has a P/E ratio of 33.13, a P/BV ratio of 4.72 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker NBIX.

Market cap

$ 14.18 Billions

Equity

$ 3.00 Billions

US$ 3,003,600,000.00

Assets

$ 4.27 Billions

US$ 4,265,700,000.00

Total Shares Outstanding

99.00 Millions

99,000,000

Average Daily Trading Volume

$ 875.75 Thousand

US$ 875,750.28

Sector

Health Care

Industry

Biotechnology

NBIX

NBIX revenue and profits

Financial Results NBIX

DRAG THE FRAME TO SEE MORE DATA

NBIX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 846.24 39,44% (12M)

P/E

26.20

0.35%

ROE

-697.75%

P/BV

-182.78

CAH - Cardinal Health

$ 206.06 72,76% (12M)

P/E

30.39

1.00%

ROE

-58.40%

P/BV

-17.75

JNJ - Johnson & Johnson

$ 195.25 33,65% (12M)

P/E

17.89

2.72%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 92.93 --2,02% (12M)

P/E

11.32

3.76%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.79 13,30% (12M)

P/E

13.89

7.12%

ROE

10.56%

P/BV

1.47

ABBV - AbbVie

$ 232.29 41,72% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 88.61 39,15% (12M)

P/E

27.91

1.85%

ROE

20.45%

P/BV

5.71

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 846.24 39,44% (12 M)

P/L

26.20

0.35%

ROE

-697.75%

P/VP

-182.78

CAH - Cardinal Health

$ 206.06 72,76% (12 M)

P/L

30.39

1.00%

ROE

-58.40%

P/VP

-17.75

JNJ - Johnson & Johnson

$ 195.25 33,65% (12 M)

P/L

17.89

2.72%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 92.93 --2,02% (12 M)

P/L

11.32

3.76%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.79 13,30% (12 M)

P/L

13.89

7.12%

ROE

10.56%

P/VP

1.47

ABBV - AbbVie

$ 232.29 41,72% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 88.61 39,15% (12 M)

P/L

27.91

1.85%

ROE

20.45%

P/VP

5.71

Frequently Asked Questions

What is the price of Neurocrine (NBIX) today?

The price of Neurocrine (NBIX) today is $ 144.17, with return of 14.86% compared to the last year. The price of Neurocrine (NBIX) started the year trading around $ 136.50 and today it is at $ 144.17. Follow the real-time price chart, the historical price of Neurocrine (NBIX) and international markets.

When does Neurocrine (NBIX) pay dividends?

Neurocrine (NBIX) did not distribute dividends in the last year.

Is Neurocrine (NBIX) worth it?

Currently, Neurocrine (NBIX) is priced at $ 144.17, with a P/E of 33.13%, representando um desvio de 5,779% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 14.86 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 14.86%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Neurocrine (NBIX) stock?

Investing in stocks of Neurocrine (NBIX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Neurocrine (NBIX) yield today?

The yield of Neurocrine (NBIX) was 5.05% in the last month, 14.86% in the last year and 55.08% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Neurocrine (NBIX) today, the total investment would be $ 14,416.50, based on the current price of $ 144.17.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 16,558.79
In 5 years: $ 22,357.11
In 10 years: $ 38,295.99

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NBIX

Neurocrine Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of NBIX

review the fundamentals of Neurocrine shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Neurocrine

Neurocrine Biosciences Inc.

United States

33 years

1996

845

PROFIT X PRICE NBIX

Financial Results NBIX

NBIX cash flow

asset growth - NBIX

NBIX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions